ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Merck KGaA and the International Vaccine Institute are joining to develop improved vaccine manufacturing processes using funding and expertise provided by the German firm. The partners seek to advance vaccine manufacture by raising process yields and improving purification steps, particularly for vaccines destined for developing countries. Their initial focus will be a vaccine for typhoid.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X